Skip to main content
Erschienen in: Diabetologia 10/2013

01.10.2013 | Article

Circulating miR-130b mediates metabolic crosstalk between fat and muscle in overweight/obesity

verfasst von: Yu-cheng Wang, Yuying Li, Xin-yi Wang, Duo Zhang, Huihui Zhang, Qi Wu, Yu-qing He, Jian-ying Wang, Lian Zhang, Hongfeng Xia, Jun Yan, Xihua Li, Hao Ying

Erschienen in: Diabetologia | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Adipose tissue is a dynamic endocrine organ that regulates whole-body energy homeostasis through the secretion of signalling molecules. Recent reports suggest that secreted microRNAs (miRNAs) may function as biologically active molecules for intercellular communication. This study aims to identify obesity-related circulating miRNA that could be secreted from adipocytes and to explore its possible role in the pathogenesis of metabolic diseases.

Methods

Real-time RT-PCR was used to evaluate the circulating level of miR-130b in mouse models of obesity as well as in humans. Luciferase assay and immunoblotting were used to verify the miRNA target. The effect of miR-130b on mouse peroxisome proliferator-activated receptor γ coactivator-1α was also investigated by electrogene transfer.

Results

The circulating level of miR-130b was elevated in mouse models of obesity as well as in obese Chinese individuals. More interestingly, the circulating level of miR-130b was positively correlated with BMI. Moreover, circulating miR-130b was a better predictor of the metabolic syndrome than was triacylglycerol level. Mechanistically, adipocytes secreted miR-130b during adipogenesis. TGF-β, which is proportionately increased with obesity, stimulated miR-130b secretion from adipocytes. Furthermore, miR-130b was able to target muscle cells and reduce the expression of its direct target gene, PGC-1α (also known as PPARGC1A), which plays a key role in lipid oxidation in muscle.

Conclusions/interpretation

Circulating miR-130b reflects the degree of obesity and could serve as a potential biomarker for hypertriacylglycerolaemia and metabolic syndrome. Circulating miR-130b could function as a metabolic mediator for adipose–muscle crosstalk and might be involved in the pathogenesis of obesity-associated metabolic diseases.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ahima RS, Lazar MA (2008) Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol 22:1023–1031PubMedCrossRef Ahima RS, Lazar MA (2008) Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol 22:1023–1031PubMedCrossRef
2.
Zurück zum Zitat Zamani N, Brown CW (2011) Emerging roles for the transforming growth factor-β superfamily in regulating adiposity and energy expenditure. Endocr Rev 32:387–403PubMedCrossRef Zamani N, Brown CW (2011) Emerging roles for the transforming growth factor-β superfamily in regulating adiposity and energy expenditure. Endocr Rev 32:387–403PubMedCrossRef
3.
Zurück zum Zitat Yadav H, Quijano C, Kamaraju AK et al (2011) Protection from obesity and diabetes by blockade of TGF-beta/Smad3 signaling. Cell Metab 14:67–79PubMedCrossRef Yadav H, Quijano C, Kamaraju AK et al (2011) Protection from obesity and diabetes by blockade of TGF-beta/Smad3 signaling. Cell Metab 14:67–79PubMedCrossRef
4.
Zurück zum Zitat Fain JN, Tichansky DS, Madan AK (2005) Transforming growth factor beta1 release by human adipose tissue is enhanced in obesity. Metabolism 54:1546–1551PubMedCrossRef Fain JN, Tichansky DS, Madan AK (2005) Transforming growth factor beta1 release by human adipose tissue is enhanced in obesity. Metabolism 54:1546–1551PubMedCrossRef
5.
Zurück zum Zitat Alessi MC, Bastelica D, Morange P et al (2000) Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes 49:1374–1380PubMedCrossRef Alessi MC, Bastelica D, Morange P et al (2000) Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes 49:1374–1380PubMedCrossRef
6.
Zurück zum Zitat Samad F, Yamamoto K, Pandey M, Loskutoff DJ (1997) Elevated expression of transforming growth factor-beta in adipose tissue from obese mice. Mol Med 3:37–48PubMed Samad F, Yamamoto K, Pandey M, Loskutoff DJ (1997) Elevated expression of transforming growth factor-beta in adipose tissue from obese mice. Mol Med 3:37–48PubMed
7.
Zurück zum Zitat Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102–114PubMedCrossRef Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102–114PubMedCrossRef
8.
Zurück zum Zitat Chen X, Gao C, Li H et al (2010) Identification and characterization of microRNAs in raw milk during different periods of lactation, commercial fluid, and powdered milk products. Cell Res 20:1128–1137PubMedCrossRef Chen X, Gao C, Li H et al (2010) Identification and characterization of microRNAs in raw milk during different periods of lactation, commercial fluid, and powdered milk products. Cell Res 20:1128–1137PubMedCrossRef
9.
Zurück zum Zitat Michael A, Bajracharya SD, Yuen PS et al (2010) Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis 16:34–38PubMedCrossRef Michael A, Bajracharya SD, Yuen PS et al (2010) Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis 16:34–38PubMedCrossRef
10.
Zurück zum Zitat Zen K, Zhang C-Y (2012) Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev 32:326–348PubMedCrossRef Zen K, Zhang C-Y (2012) Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev 32:326–348PubMedCrossRef
11.
Zurück zum Zitat Chen X, Liang H, Zhang J, Zen K, Zhang CY (2012) Horizontal transfer of microRNAs: molecular mechanisms and clinical applications. Protein Cell 3:28–37PubMedCrossRef Chen X, Liang H, Zhang J, Zen K, Zhang CY (2012) Horizontal transfer of microRNAs: molecular mechanisms and clinical applications. Protein Cell 3:28–37PubMedCrossRef
12.
Zurück zum Zitat Mittelbrunn M, Gutierrez-Vazquez C, Villarroya-Beltri C et al (2011) Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun 2:282PubMedCrossRef Mittelbrunn M, Gutierrez-Vazquez C, Villarroya-Beltri C et al (2011) Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun 2:282PubMedCrossRef
13.
Zurück zum Zitat Ogawa R, Tanaka C, Sato M et al (2010) Adipocyte-derived microvesicles contain RNA that is transported into macrophages and might be secreted into blood circulation. Biochem Biophys Res Commun 398:723–729PubMedCrossRef Ogawa R, Tanaka C, Sato M et al (2010) Adipocyte-derived microvesicles contain RNA that is transported into macrophages and might be secreted into blood circulation. Biochem Biophys Res Commun 398:723–729PubMedCrossRef
14.
Zurück zum Zitat Bengestrate L, Virtue S, Campbell M et al (2011) Genome-wide profiling of microRNAs in adipose mesenchymal stem cell differentiation and mouse models of obesity. PLoS One 6:e21305PubMedCrossRef Bengestrate L, Virtue S, Campbell M et al (2011) Genome-wide profiling of microRNAs in adipose mesenchymal stem cell differentiation and mouse models of obesity. PLoS One 6:e21305PubMedCrossRef
15.
Zurück zum Zitat Keller P, Gburcik V, Petrovic N et al (2011) Gene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity. BMC Endocr Disord 11:7PubMedCrossRef Keller P, Gburcik V, Petrovic N et al (2011) Gene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity. BMC Endocr Disord 11:7PubMedCrossRef
16.
Zurück zum Zitat Heneghan HM, Miller N, McAnena OJ, O'Brien T, Kerin MJ (2011) Differential miRNA expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers. J Clin Endocrinol Metab 96:E846–E850PubMedCrossRef Heneghan HM, Miller N, McAnena OJ, O'Brien T, Kerin MJ (2011) Differential miRNA expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers. J Clin Endocrinol Metab 96:E846–E850PubMedCrossRef
17.
Zurück zum Zitat Ortega FJ, Mercader JM, Catalan V et al (2013) Targeting the circulating microRNA signature of obesity. Clin Chem 59:781–792PubMedCrossRef Ortega FJ, Mercader JM, Catalan V et al (2013) Targeting the circulating microRNA signature of obesity. Clin Chem 59:781–792PubMedCrossRef
18.
Zurück zum Zitat Ying H, Araki O, Furuya F, Kato Y, Cheng SY (2007) Impaired adipogenesis caused by a mutated thyroid hormone alpha1 receptor. Mol Cell Biol 27:2359–2371PubMedCrossRef Ying H, Araki O, Furuya F, Kato Y, Cheng SY (2007) Impaired adipogenesis caused by a mutated thyroid hormone alpha1 receptor. Mol Cell Biol 27:2359–2371PubMedCrossRef
19.
Zurück zum Zitat Zhang D, Li X, Chen C et al (2012) Attenuation of p38-mediated miR-1/133 expression facilitates myoblast proliferation during the early stage of muscle regeneration. PLoS One 7:e41478PubMedCrossRef Zhang D, Li X, Chen C et al (2012) Attenuation of p38-mediated miR-1/133 expression facilitates myoblast proliferation during the early stage of muscle regeneration. PLoS One 7:e41478PubMedCrossRef
20.
Zurück zum Zitat Wang Y, Mi J, Shan XY, Wang QJ, Ge KY (2007) Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond) 31:177–188CrossRef Wang Y, Mi J, Shan XY, Wang QJ, Ge KY (2007) Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond) 31:177–188CrossRef
21.
Zurück zum Zitat Chen C, Ridzon DA, Broomer AJ et al (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33:e179PubMedCrossRef Chen C, Ridzon DA, Broomer AJ et al (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33:e179PubMedCrossRef
22.
Zurück zum Zitat Song Y, Shan S, Zhang Y et al (2012) Ligand-dependent corepressor acts as a novel corepressor of thyroid hormone receptor and represses hepatic lipogenesis in mice. J Hepatol 56:248–254PubMedCrossRef Song Y, Shan S, Zhang Y et al (2012) Ligand-dependent corepressor acts as a novel corepressor of thyroid hormone receptor and represses hepatic lipogenesis in mice. J Hepatol 56:248–254PubMedCrossRef
23.
Zurück zum Zitat Sandri M, Sandri C, Gilbert A et al (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117:399–412PubMedCrossRef Sandri M, Sandri C, Gilbert A et al (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117:399–412PubMedCrossRef
24.
Zurück zum Zitat Sun L, Franco OH, Hu FB et al (2008) Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly Chinese. J Clin Endocrinol Metab 93:4690–4696PubMedCrossRef Sun L, Franco OH, Hu FB et al (2008) Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly Chinese. J Clin Endocrinol Metab 93:4690–4696PubMedCrossRef
25.
Zurück zum Zitat Lee EK, Lee MJ, Abdelmohsen K et al (2011) miR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor gamma expression. Mol Cell Biol 31:626–638PubMedCrossRef Lee EK, Lee MJ, Abdelmohsen K et al (2011) miR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor gamma expression. Mol Cell Biol 31:626–638PubMedCrossRef
26.
Zurück zum Zitat Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T (2010) Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285:17442–17452PubMedCrossRef Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T (2010) Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285:17442–17452PubMedCrossRef
27.
Zurück zum Zitat Nikolic N, Rhedin M, Rustan AC, Storlien L, Thoresen GH, Stromstedt M (2012) Overexpression of PGC-1alpha increases fatty acid oxidative capacity of human skeletal muscle cells. Biochem Res Int 2012:714074PubMed Nikolic N, Rhedin M, Rustan AC, Storlien L, Thoresen GH, Stromstedt M (2012) Overexpression of PGC-1alpha increases fatty acid oxidative capacity of human skeletal muscle cells. Biochem Res Int 2012:714074PubMed
28.
Zurück zum Zitat Schuler M, Ali F, Chambon C et al (2006) PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell Metab 4:407–414PubMedCrossRef Schuler M, Ali F, Chambon C et al (2006) PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell Metab 4:407–414PubMedCrossRef
29.
Zurück zum Zitat Sparks LM, Xie H, Koza RA et al (2005) A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 54:1926–1933PubMedCrossRef Sparks LM, Xie H, Koza RA et al (2005) A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 54:1926–1933PubMedCrossRef
Metadaten
Titel
Circulating miR-130b mediates metabolic crosstalk between fat and muscle in overweight/obesity
verfasst von
Yu-cheng Wang
Yuying Li
Xin-yi Wang
Duo Zhang
Huihui Zhang
Qi Wu
Yu-qing He
Jian-ying Wang
Lian Zhang
Hongfeng Xia
Jun Yan
Xihua Li
Hao Ying
Publikationsdatum
01.10.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 10/2013
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-2996-8

Weitere Artikel der Ausgabe 10/2013

Diabetologia 10/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.